iBio Forms Marketing Collaboration With Kanematsu Chemicals Corporation to Target Japanese Market
14 août 2014 08h31 HE | iBio, Inc.
NEWARK, DE--(Marketwired - Aug 14, 2014) - iBio, Inc. (NYSE MKT: IBIO), and Kanematsu Chemicals Corporation, part of Kanematsu Corporation (TSE: 8020), have entered into a collaboration agreement...
iBio Appoints Another IPF Expert, Dr. J. Terrill Huggins, to Clinical Advisory Board
30 juil. 2014 08h31 HE | iBio, Inc.
NEWARK, DE--(Marketwired - Jul 30, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed J....
iBio Appoints Dr. Richard M. Silver to Clinical Advisory Board
21 juil. 2014 08h31 HE | iBio, Inc.
NEWARK, DE--(Marketwired - Jul 21, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed Richard...
iBio Appoints Dr. Timothy Blackwell to New Clinical Advisory Board
16 juil. 2014 08h31 HE | iBio, Inc.
NEWARK, DE--(Marketwired - Jul 16, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, has appointed Timothy...
iBio Expands Commercial Collaboration With Bio-Manguinhos and Fraunhofer
17 juin 2014 08h31 HE | iBio, Inc.
NEWARK, DE--(Marketwired - Jun 17, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, amended its...
iBio Expands IP Protection of Biotherapeutic Product for Treatment of Fibrosis
10 juin 2014 08h31 HE | iBio, Inc.
NEWARK, DE--(Marketwired - Jun 10, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the issue by...
iBio European Patent on iBioModulator Technology Emerges From Opposition Period
05 juin 2014 08h31 HE | iBio, Inc.
NEWARK, DE--(Marketwired - Jun 5, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, has surpassed the opposition...
iBio Receives Patent Allowance in China for Fusion Protein Compositions and Technology
24 avr. 2014 08h31 HE | iBio, Inc.
NEWARK, DE--(Marketwired - Apr 24, 2014) -   iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, reported the allowance...
iBio Receives Patent Allowances for Pandemic Influenza Therapeutics
27 mars 2014 08h31 HE | iBio, Inc.
NEWARK, DE--(Marketwired - Mar 27, 2014) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, reported the allowance of two U.S....
Transdermal Patch Delivery Technologies Will Create New Blockbuster Drugs
25 mars 2014 07h30 HE | Lux Research
BOSTON, MA--(Marketwired - Mar 25, 2014) - Driven by convergence with other platform-enhancing technologies and shifting demographics, transdermal delivery of drugs (through the skin) is poised for...